Rasio utang jangka cendhak marang ekuitas: CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO) utilizes bioinformatic IT systems for the computer-aided synthesis of anti-neurodegeneration agents, minimizing manual labor. Business development relies on patents and the success of clinical trials for Alzheimer's disease drugs, while the asset value tracked on the chart is 0.00. The company is developing unique treatments for Lewy body dementia, aiming to capture a market free of competition.
Rincian metrik lan analitis perusahaan cervomed.com (CRVO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal CervoMed Inc.|CRVO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal CervoMed|CRVO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku CervoMed, Inc.|CRVO - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan CervoMed|Likuiditas cepet cervomed.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis kabeh metrik perusahaan:CRVO CervoMed Inc
CervoMed Inc. (CRVO) development of dementia therapies requires significant expenditures, making the control of short-term liabilities relative to equity critical for maintaining liquidity. This ratio measures the company's reliance on short-term borrowing, allowing investors to assess the risk of resource shortages for clinical trials by analyzing the short-term debt to equity chart.
Pesaing langsung
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas denalitherapeutics.com (DNLI)|Utang jangka cendhak marang modal HRMY|BHVN - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Amylyx AMLX|Rasio tanggungan utang jangka cendhak marang modal TRVI|PRAX: Rasio utang jangka cendhak marang ekuitas|AVXL: Utang jangka cendhak marang ekuitas|CeriBell (CBLL) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Prothena Biosciences (PRTA)|Utang jangka cendhak marang ekuitas Alector Inc.|Rasio utang jangka cendhak marang ekuitas Annexon Biosciences Inc. (ANNX)|Utang jangka cendhak marang modal OMER|NGNE - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal ACIU (AC Immune SA)|VYGR: Rasio utang jangka cendhak marang modal|NMRA: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal SCLX (Scilex Holding Company, Inc.)|TVGN: Utang jangka cendhak marang modal|ACOG - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cognition Therapeutics, Inc.|Rasio utang jangka cendhak marang modal IKT (Inhibikase Therapeutics Inc)|Utang jangka cendhak marang modal SAVA|Rasio utang jangka cendhak marang ekuitas assertiotx.com ASRT|Coya Therapeutics - Rasio utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal VistaGen Therapeutics, Inc. (VTGN)|Ovid Rx - Utang jangka cendhak marang modal|Acumen Pharmaceuticals Inc. (ABOS) - Rasio utang jangka cendhak marang ekuitas|alteritytherapeutics.com (ATHE) - Utang jangka cendhak marang ekuitas|Clene - Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas PEPG|Utang jangka cendhak marang ekuitas JUNS|Utang jangka cendhak marang ekuitas Relmada Therapeutics, Inc. (RLMD)|ANVS - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Grace Therapeutics GRCE|AIFF: Rasio utang jangka cendhak marang modal|ANEW Medical, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Rasio utang jangka cendhak marang ekuitas|MetaVia (MTVA) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NeurAxis, Inc|HSDT: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Passage Bio, Inc. (PASG)|NEUP - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal NERV (Minerva Neurosciences, Inc.)|ATHA - Rasio utang jangka cendhak marang ekuitas|Addex Therapeutics, Ltd. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Alzamend Neuro, Inc.|cyclerion.com (CYCN) - Utang jangka cendhak marang ekuitas|Protagenic Therapeutics, Inc. - Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas KTTA|Utang jangka cendhak marang ekuitas CRGT|Utang jangka cendhak marang ekuitas Avenue Therapeutics, Inc (ATXI)|BCLI - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|CHRO - Rasio utang jangka cendhak marang ekuitas|Eliem - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Intra-Cellular Therapies|LBPH: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal MRNS|Rasio utang jangka cendhak marang ekuitas NKGN|NRBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal SAGE|Koefisien utang jangka cendhak marang modal Synaptogenix Inc.|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|VIGL: Rasio utang jangka cendhak marang modal|Anew Medical, Inc. - Utang jangka cendhak marang modal|cerevel.com (CERE) - Rasio utang jangka cendhak marang ekuitas